Maze Therapeutics (MAZE) Profit After Tax (2024 - 2026)
Maze Therapeutics (MAZE) reported Profit After Tax of -$24.2 million for Q1 2026, up 26.16% on a YoY basis from -$19.2 million in Q1 2025, and up 29.97% sequentially from -$34.6 million in Q4 2025.
Maze Therapeutics (MAZE) Profit After Tax (2024 - 2026) Analysis & Trends
Maze Therapeutics (MAZE) has 3 years of Profit After Tax data on file, last reported at -$24.2 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 26.16% year-over-year to -$24.2 million; the trailing twelve-month figure through Mar 2026 stood at -$122.5 million (down 261.47% YoY), and the FY2025 full-year result was -$131.1 million, down 3950.81% from the prior year.
- Profit After Tax climbed to -$24.2 million in Q1 2026, from -$34.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $139.1 million in Q2 2024 to a low of -$34.6 million in Q4 2025.
- A 3-year average of -$8.8 million and a median of -$30.1 million in 2025 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax plunged 514.43% in 2025 and rose 26.16% in 2026, its largest moves.
- Tracing MAZE's Profit After Tax over 3 years: stood at -$5.6 million in 2024, then sank by 514.43% to -$34.6 million in 2025, then grew by 29.97% to -$24.2 million in 2026.
- Business Quant data shows MAZE's Profit After Tax at -$24.2 million in Q1 2026, -$34.6 million in Q4 2025, and -$30.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Maze Therapeutics | 1.49 Bn | 1.49 Bn | 18.21 Mn | -24.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.21 Mn |
| Dec 31, 2025 | -34.57 Mn |
| Sep 30, 2025 | -30.09 Mn |
| Jun 30, 2025 | -33.68 Mn |
| Mar 31, 2025 | -32.79 Mn |
| Dec 31, 2024 | -5.63 Mn |
| Sep 30, 2024 | -24.75 Mn |
| Jun 30, 2024 | 139.06 Mn |
| Mar 31, 2024 | -32.49 Mn |